SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

74,294.96 -19.63
( -0.03%)

Global Indices

Nasdaq

51,795.38 312.48
(0.61%)

Dow Jones

7,657.54 84.73
(1.12%)

Hang Seng

65,040.24 903.99
(1.41%)

Nikkei 225

10,816.25 127.78
(1.20%)

Forex

USD-INR

95.66 0.25
(0.26%)

EUR-INR

110.22 0.12
(0.11%)

GBP-INR

128.62 0.00
(0.00%)

JPY-INR

0.62 0.00
(-0.04%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

78871

INE0L4V01013

18.6032787

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

VILINBIO

47.62

91.5

EPS(TTM)

Face Value()

Div & Yield %

1.26

Back

Prime Capital Market reports standalone net loss of Rs 1.40 crore in the June 2026 quarter

Aug 13,2026

Net loss of Prime Capital Market reported to Rs 1.40 crore in the quarter ended June 2026 as against net profit of Rs 0.01 crore during the previous quarter ended June 2025. Sales rose 82.72% to Rs 1.48 crore in the quarter ended June 2026 as against Rs 0.81 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	1.48	0.81	83
OPM %	-76.35	1.23	-
PBDT	-1.40	0.01	PL
PBT	-1.40	0.01	PL
NP	-1.40	0.01	PL

74,294.96 -19.63 ( -0.03%)

51,795.38 312.48 (0.61%)

7,657.54 84.73 (1.12%)

65,040.24 903.99 (1.41%)

10,816.25 127.78 (1.20%)

95.66 0.25 (0.26%)

110.22 0.12 (0.11%)

128.62 0.00 (0.00%)

0.62 0.00 (-0.04%)